Completed
Phase III Clinical Trial of Y-2 Sublingual Tablets in the Treatment of Acute Ischemic Stroke
NCT04950920
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +4 more
- Locations
-
- Peking University Third Hospital Beijin, China